about
Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.Transcript and protein analysis reveals better survival skills of monocyte-derived dendritic cells compared to monocytes during oxidative stress.Dissecting out the complex Ca2+-mediated phenylephrine-induced contractions of mouse aortic segments.Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability.Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis.Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in miceTolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?Dipeptidyl peptidase II and leukocyte cell death.mRNA but not plasmid DNA is efficiently transfected in murine J774A.1 macrophages.Immunohistochemical analysis of macroautophagy: recommendations and limitations.Effect of angiotensin II-induced arterial hypertension on the voltage-dependent contractions of mouse arteries.Contribution of α-adrenoceptor stimulation by phenylephrine to basal nitric oxide production in the isolated mouse aorta.Phagocytosis of bacteria is enhanced in macrophages undergoing nutrient deprivation.Chronic intermittent mental stress promotes atherosclerotic plaque vulnerability, myocardial infarction and sudden death in mice.Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis.Flow cytometric evaluation of a model for phagocytosis of cells undergoing apoptosis.Selective loss of basal but not receptor-stimulated relaxation by endothelial nitric oxide synthase after isolation of the mouse aorta.Nucleofection as an efficient nonviral transfection method for human monocytic cells.Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid
P50
Q30646015-9EFC4CC9-F01F-40C7-8BC2-E56C61FA323EQ34391537-3C83765D-0A2E-4CB4-B068-18CC977DF2C1Q35214438-9A597A62-A6A7-43F5-AEF4-19C68171B656Q36644805-11D96322-4973-43FB-9BE3-81FFAF061391Q36777324-115D9003-A877-4C3C-B931-F2D2E0156B2FQ37143384-4F2E2133-F55A-4443-8EEB-7E5B259EA695Q38152155-47156954-80E6-40CF-869F-F8101BA6E47DQ40275294-320062E5-2D51-4B86-B351-A03EB6892BA4Q40475485-3A81CF3F-B00D-45DF-8CF1-836BB1D1B34EQ41520356-19159EEA-88C9-4616-8195-6D5E440B6E28Q42483189-4D936719-8928-4722-817B-D2CA30E8216FQ42518073-558BC775-1361-4E25-8AF2-5D64D50F0835Q46080680-4D292289-E51C-4C4B-A1B4-A0C1618FAAD3Q50576198-29417D15-CEC9-45FC-A3EF-47E4CA84DCBAQ50769120-FC18E213-9634-4FAE-8BEE-23A9F938F206Q51685924-BCC6D981-B9A9-47B1-8A1F-6B8BD205694DQ54480852-201B7876-764A-496E-962B-80625425410FQ54521000-CCF2AD37-AA3C-4882-9D12-B3DF7B04E662Q83466246-D159A7F3-44E3-4EEF-8641-03F24973D0C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dorien M Schrijvers
@ast
Dorien M Schrijvers
@en
Dorien M Schrijvers
@es
Dorien M Schrijvers
@nl
Dorien M Schrijvers
@sl
type
label
Dorien M Schrijvers
@ast
Dorien M Schrijvers
@en
Dorien M Schrijvers
@es
Dorien M Schrijvers
@nl
Dorien M Schrijvers
@sl
prefLabel
Dorien M Schrijvers
@ast
Dorien M Schrijvers
@en
Dorien M Schrijvers
@es
Dorien M Schrijvers
@nl
Dorien M Schrijvers
@sl
P106
P31
P496
0000-0003-0826-4943